Literature DB >> 23765617

Analysis of peptides by denaturing ultrafiltration and LC-MALDI-TOF-MS.

Yanming An1, Radoslav Goldman.   

Abstract

The dynamic range of complex biological samples represents a challenge for mass spectrometric -characterization. Removal of high abundant proteins is a prerequisite for a successful mass spectrometric analysis of low abundant analytes. In particular, plasma and serum proteome span at least ten orders of magnitude and represent a major challenge for biomarker discovery. Immunoaffinity depletion is the most common methods of removal of high abundant proteins. Here we describe coupling of denaturing ultrafiltration, an alternative depletion strategy, with reverse-phase fractionation and mass spectrometry for characterization of low-molecular-weight proteins and peptides.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23765617      PMCID: PMC5370547          DOI: 10.1007/978-1-4614-7209-4_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  22 in total

1.  Characterization of the low molecular weight human serum proteome.

Authors:  Radhakrishna S Tirumalai; King C Chan; DaRue A Prieto; Haleem J Issaq; Thomas P Conrads; Timothy D Veenstra
Journal:  Mol Cell Proteomics       Date:  2003-08-13       Impact factor: 5.911

2.  Low-molecular-weight human serum proteome using ultrafiltration, isoelectric focusing, and mass spectrometry.

Authors:  Robert G Harper; Sarah R Workman; Shayne Schuetzner; Aaron T Timperman; Jennifer N Sutton
Journal:  Electrophoresis       Date:  2004-05       Impact factor: 3.535

3.  Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display.

Authors:  Harald Tammen; Imke Schulte; Rudiger Hess; Christoph Menzel; Markus Kellmann; Thomas Mohring; Peter Schulz-Knappe
Journal:  Proteomics       Date:  2005-08       Impact factor: 3.984

4.  Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma.

Authors:  Eduard Orvisky; Steven K Drake; Brian M Martin; Mohamed Abdel-Hamid; Habtom W Ressom; Rency S Varghese; Yanming An; Daniel Saha; Glen L Hortin; Christopher A Loffredo; Radoslav Goldman
Journal:  Proteomics       Date:  2006-05       Impact factor: 3.984

5.  A sequence-specific exopeptidase activity test (SSEAT) for "functional" biomarker discovery.

Authors:  Josep Villanueva; Arpi Nazarian; Kevin Lawlor; San San Yi; Richard J Robbins; Paul Tempst
Journal:  Mol Cell Proteomics       Date:  2007-11-06       Impact factor: 5.911

6.  Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer.

Authors:  Xiaoyang Zheng; Haven Baker; William S Hancock
Journal:  J Chromatogr A       Date:  2006-03-09       Impact factor: 4.759

7.  SISCAPA peptide enrichment on magnetic beads using an in-line bead trap device.

Authors:  N Leigh Anderson; Angela Jackson; Derek Smith; Darryl Hardie; Christoph Borchers; Terry W Pearson
Journal:  Mol Cell Proteomics       Date:  2009-02-04       Impact factor: 5.911

8.  Derivatized mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine.

Authors:  Rosa Terracciano; Luigi Pasqua; Francesca Casadonte; Stella Frascà; Mariaimmacolata Preianò; Daniela Falcone; Rocco Savino
Journal:  Bioconjug Chem       Date:  2009-05-20       Impact factor: 4.774

9.  Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection.

Authors:  Xuefeng B Ling; Tara K Sigdel; Kenneth Lau; Lihua Ying; Irwin Lau; James Schilling; Minnie M Sarwal
Journal:  J Am Soc Nephrol       Date:  2010-02-11       Impact factor: 10.121

10.  Performing comparative peptidomics analyses of Salmonella from different growth conditions.

Authors:  Joshua N Adkins; Heather Mottaz; Thomas O Metz; Charles Ansong; Nathan P Manes; Richard D Smith; Fred Heffron
Journal:  Methods Mol Biol       Date:  2010
View more
  1 in total

Review 1.  Coupling enrichment methods with proteomics for understanding and treating disease.

Authors:  Amit Kumar; Deniz Baycin-Hizal; Joseph Shiloach; Michael A Bowen; Michael J Betenbaugh
Journal:  Proteomics Clin Appl       Date:  2015-01-19       Impact factor: 3.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.